Progress analysis of short course treatment for tuberculosis
结核病短程治疗方案的进展分析

摘要

现阶段，结核病疫情减少，但与世界卫生组织制定的“终止结核病策略”目标仍存在明显间隔，因此开发并实施高效短程治疗方法显得尤为关键。本文目的是研究结核病短程治疗进展，对现行治疗手段进行效果评估，期望为将来结核病短程治疗方法的进一步完善提供有力的参考与依据。近年来，随着新技术在结核领域的不断渗透与创新，新型短程化疗药物不断涌现，使得结核病短程治疗进入全新时期。总体上看，短程治疗能够显着降低结核复发风险、缩短疗程、改善临床结局。虽然面临诸多挑战，但通过新型药物的研发、药物剂量的优化以及更为精确的患者评价，结核病的短程治疗有望在接下来的几年里实现明显的进步。

Abstract

At this stage, the epidemic situation of tuberculosis has decreased, but there is still a significant gap between it and the goal of "Stop tuberculosis strategy" formulated by the World Health Organization, so it is particularly critical to develop and implement efficient short-term treatment methods. The purpose of this paper is to study the progress of short-term treatment for tuberculosis, evaluate the effect of current treatment methods, and hope to provide a strong reference and basis for further improvement of short-term treatment methods for tuberculosis in the future. In recent years, with the continuous penetration and innovation of new technologies in the field of tuberculosis, new short-range chemotherapy drugs continue to emerge, making short-range treatment of tuberculosis enter a new era. Overall, short-term treatment can significantly reduce the risk of tuberculosis recurrence, shorten the course of treatment, and improve clinical outcomes. Although facing many challenges, through the research and development of new drugs, optimization of drug dosage and more accurate patient evaluation, the short-term treatment of tuberculosis is expected to achieve significant progress in the next few years.